The EANM guideline on radioiodine therapy of benign thyroid disease
European Journal of Nuclear Medicine and Molecular Imaging · 2023-09 · 50 (11) · 3324-3348
DOI: 10.1007/s00259-023-06274-5 ↗Kurz gefasst
Leitlinie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 03.07.2023. Verfasst von Alfredo Campennì und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, Unit of Nuclear Medicine, University of Messina, Messina, Italy. Hauptthemen laut MEDLINE: Graves Disease, Thyroid Diseases, Radiation Protection. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This document provides the new EANM guideline on radioiodine therapy of benign thyroid disease. Its aim is to guide nuclear medicine physicians, endocrinologists, and practitioners in the selection of patients for radioiodine therapy. Its recommendations on patients’ preparation, empiric and dosimetric therapeutic approaches, applied radioiodine activity, radiation protection requirements, and patients follow-up after administration of radioiodine therapy are extensively discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, Unit of Nuclear Medicine, University of Messina, Messina, Italy.
- Departments of Radiology and Medicine, MetroHealth Hospital, Case Western Reserve University, Cleveland, OH, USA.
- Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands. f.verburg@erasmusmc.nl.
- Academic Department of Nuclear Medicine, University Hospital AHEPA, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- Academic Department of Nuclear Medicine, General Hospital Papageorgiou, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
ORCID-Profile: Frederik A Verburg
Zitieren
APA
Campennì, A., Avram, A. M., Verburg, F. A., Iakovou, I., Hänscheid, H., de Keizer, B., Petranović Ovčariček, P., & Giovanella, L. (2023). The EANM guideline on radioiodine therapy of benign thyroid disease. European Journal of Nuclear Medicine and Molecular Imaging, 50(11), 3324-3348. https://doi.org/10.1007/s00259-023-06274-5
Vancouver
Campennì A, Avram AM, Verburg FA, Iakovou I, Hänscheid H, de Keizer B, et al. The EANM guideline on radioiodine therapy of benign thyroid disease. European Journal of Nuclear Medicine and Molecular Imaging. 2023;50(11):3324-3348. doi:10.1007/s00259-023-06274-5
BibTeX
@article{Campenn2023,
author = {Campennì, Alfredo and Avram, Anca M and Verburg, Frederik A and Iakovou, Ioannis and Hänscheid, Heribert and de Keizer, Bart and Petranović Ovčariček, Petra and Giovanella, Luca},
title = {The EANM guideline on radioiodine therapy of benign thyroid disease},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2023},
volume = {50},
number = {11},
pages = {3324--3348},
doi = {10.1007/s00259-023-06274-5}
}
EUVIMED